About: Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 12 February 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) im Februar 2019 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 2019 (ast) scientific article published on 12 February 2019 (en) 2019 թվականի փետրվարի 12-ին հրատարակված գիտական հոդված (hy) наукова стаття, опублікована 12 лютого 2019 (uk)
publication date	wds:Q91631473-ADA77ED9-0E2A-4A89-B8C7-F493CC24A68D
publication date	2019-02-12 00:00:00Z (xsd:dateTime)
cites work	wds:Q91631473-08EA9E76-6142-417D-B58C-656C31360054 wds:Q91631473-119DF78E-394A-4150-8166-212C20FDB4CD wds:Q91631473-149CC12F-EECC-4777-AEFA-B825DE491C20 wds:Q91631473-1F5AC499-9110-4170-B742-DC55EB031B7B wds:Q91631473-2BC26E10-298C-4958-B217-26D083003DFC wds:Q91631473-315648D1-63ED-46EB-8D87-A4F2F5756A83 wds:Q91631473-341E3A45-99FB-46EF-852E-DAABB97AE641 wds:Q91631473-52040139-0406-48E4-818D-AF99D30816E7 wds:Q91631473-71E85EAB-2B90-445A-9917-48C83CCA84F1 wds:Q91631473-7FCF0D92-92B2-40AF-B6EE-A424ADAB9433 wds:Q91631473-95F7299E-612B-4F0B-AF3A-09AAE20AB830 wds:Q91631473-9CFB2895-F3D3-4BD2-87EE-A735AA576857 wds:Q91631473-A3D51DC0-7D9B-4332-B7BB-9263CF1BC14A wds:Q91631473-AFFDC348-20C0-4E00-A230-FE2B93259FCE wds:Q91631473-B1D6F71F-C844-4CD7-90D0-73F8CB5E59CA wds:Q91631473-B9F5B1B5-4D7E-424B-8180-C61B40371F61 wds:Q91631473-C0CB7B3B-A65E-4B53-8C32-B36D7985BE80 wds:Q91631473-C2FAB790-5FB8-4916-9759-D0CC235D8165 wds:Q91631473-C6ECDF4F-DC85-4D6A-AF6B-8F10C0B2A264 wds:Q91631473-CA68BAE8-4B1A-4337-94D5-0B10D4D2E1C9 wds:Q91631473-CC860929-473A-4CEA-B296-E5CC9513BEC2 wds:Q91631473-E355DABD-2078-41A7-A309-DC5CAD132C08 wds:Q91631473-EEC68043-FBC0-4E89-A009-5CB28A3F55E0 wds:Q91631473-F32562BE-1900-4D1A-8AB4-BDAB27AB4EA9 wds:Q91631473-F344FA78-6469-4FF9-A4C5-36B25F935C7A wds:Q91631473-F4361119-FADA-4ABB-BCA4-2B55CFA00579
cites work	Human immunity to the meningococcus. I. The role of humoral antibodies Global epidemiology of invasive meningococcal disease Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease Meningococcal carriage by age: a systematic review and meta-analysis Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age Meningococcal surrogates of protection--serum bactericidal antibody activity Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults: An Open, Randomized Trial Antibody persistence and response to a booster dose of a quadrivalent conjugate vaccine for meningococcal disease in adolescents. Global incidence of serogroup B invasive meningococcal disease: a systematic review Persistence of bactericidal antibodies to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of age. Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers. The clinical features and long-term sequelae of invasive meningococcal disease in children. Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine - Advisory Committee on Immunization Practices, 2016. Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents. Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial. Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults. A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine Antibody persistence after primary and booster doses of a quadrivalent meningococcal conjugate vaccine in adolescents
author name string	wds:Q91631473-1C6B80C7-4D6E-438D-9E26-1A3677CDB90C wds:Q91631473-61A9659B-E4B8-47B8-86E8-8388A252A4A1 wds:Q91631473-8A970557-5E73-4DE5-A745-0C75018DB422 wds:Q91631473-90EE9EC1-F0D5-4FEC-9809-4AE31F9E9C64 wds:Q91631473-D3F05AA4-4E3A-47E9-9507-237D87611E37 wds:Q91631473-D740A376-D0BB-4B4C-96C5-1FAB00236428 wds:Q91631473-F59A66F2-BA07-42B4-9838-BD1C9D791E61
author name string	Thomas R Jones John L Perez Shannon L Harris Joseph J Eiden Samantha Munson Robert E O'Neill Laura J York
rdfs:label	Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents (en) Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents (nl)
skos:prefLabel	Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents (en) Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents (nl)
name	Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents (en) Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents (nl)
author	wds:Q91631473-2C455969-D4CA-4431-8C81-6BE63AEEE10D wds:Q91631473-36106937-9687-4C17-9DE4-3B82624DB4DA wds:Q91631473-8263B5B8-4640-480D-8706-62FB93B83283 wds:Q91631473-BA69E52B-6275-4DB3-9C6C-44F9A9299A9F wds:Q91631473-CFCBDE9F-FA96-4B81-9DCF-711153218817 wds:Q91631473-D6F6F80D-DC3F-4C8C-AC83-8D2C3B5B8735
author	Kathrin Jansen Lars Østergaard Timo Vesikari Judith Absalon Johannes Beeslaar Roger Maansson
title	wds:Q91631473-4ABD5D1F-7339-4FD5-B510-60FA73A8D39D
title	Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents (en)
page(s)	wds:Q91631473-308E4C7D-0C52-4A08-BB8E-067559821F9B
page(s)	1710-1719
instance of	wds:Q91631473-C36EA3C0-7C48-40F8-9CBC-22FF28281BE6
instance of	scholarly article
PubMed ID	wds:Q91631473-BE7BF4C3-ABD4-46F1-A6F9-D2851B4D8599

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software